'This is life-changing for these patients:' A biotech is skyrocketing after making a breakthrough in treating cystic fibrosis

the kids 015

If the triple combinations are approved and priced similarly, concerns about the high cost of care will multiply, said Dr. David Cornfield, a professor and pediatric pulmonologist at the Lucile Salter Packard Children’s Hospital at Stanford University.

Read more